Literature DB >> 825029

Active metabolites of isoxazolylpencillins in humans.

H H Thijssen, H Mattie.   

Abstract

Metabolites of the isoxazolylpenicillins that still possessed antibacterial activity were shown to be present in urine and serum. In healthy subjects, the amounts excreted in urine were low; 10 to 23% of the excreted penicillin activities represented the metabolites. The highest amount of metabolite in urine was found for oxacillin, and the lowest was found for flucloxacillin. No extreme differences in the amounts of metabolite excreted were observed when the compounds were administered orally or intravenously. In one healthy subject metabolite levels were estimated for cloxacillin in serum. Very low levels were found, i.e., about 9% of the activity. In subjects with highly impaired renal function, the metabolite may represent up to 50% of the total level of penicillin in serum. The antibacterial activities of the different metabolites were of the same order of magnitude as those of the respective parent compounds. Also, the activity against benzylpenicillin-resistant staphylococci was retained. It is not likely that the formation of the active metabolites should influence therapeutic results.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825029      PMCID: PMC429767          DOI: 10.1128/AAC.10.3.441

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  IDENTIFICATION OF P-HYDROXYPHENOXYMETHYL PENICILLIN AS A METABOLITE OF PHENOXYMETHYL PENICILLIN.

Authors:  H VANDERHAEGHE; G PARMENTIER; E EVRARD
Journal:  Nature       Date:  1963-11-30       Impact factor: 49.962

2.  Renal secretion of [35-S]furosemide and depression by albumin binding.

Authors:  R H Bowman
Journal:  Am J Physiol       Date:  1975-07

3.  Fate of oral 35S-cloxacillin in man.

Authors:  K Hellström; A Rosén; A Swahn
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Separation and detection of degradation products of penicillins and cephalosporins by means of thin-layer chromatography.

Authors:  E J Vandamme; J P Voets
Journal:  J Chromatogr       Date:  1972-08-23

5.  Detection and separation of penicillins by thin-layer chromatography.

Authors:  I J McGilveray; R D Strickland
Journal:  J Pharm Sci       Date:  1967-01       Impact factor: 3.534

6.  Partition data of penicillins determined by means of reversed-phase thin-layer chromatography.

Authors:  G L Biagi; A M Barbaro; M F Gamba; M C Guerra
Journal:  J Chromatogr       Date:  1969-05-20

7.  Studies on the formation and activity of the transformation product of ampicillin.

Authors:  M Nishida; T Murakawa; Y Mine; S Fukuda; Y Kono
Journal:  J Antibiot (Tokyo)       Date:  1971-09       Impact factor: 2.649

8.  Reversed-phase thin-layer chromatography and partition coefficients of penicillins.

Authors:  A E Bird; A C Marshall
Journal:  J Chromatogr       Date:  1971-12-23

9.  Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.

Authors:  E H Nauta; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

10.  Metabolism of penicillins to penicilloic acids and 6-aminopenicillanic acid in man and its significance in assessing penicillin absorption.

Authors:  M Cole; M D Kenig; V A Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  10 in total
  6 in total

1.  Re: B. L. Røder, et al.: Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration (Infection 23 [1995] 107-112)

Authors:  H H Thijssen
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

2.  Flucloxacillin kinetics in newborn infants.

Authors:  L Herngren
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Flucloxacillin kinetics in newborn infants.

Authors:  H H Thijssen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  The metabolic disposition of flucloxacillin in patients with impaired kidney function.

Authors:  H H Thijssen; J Wolters
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Comparative study of the effects of some inducers with or without protein binding properties on bioavailability of isoxazolylpenicillins in rats.

Authors:  M Couvaris; P Galanopoulou; C Karageorgiou; S Theodosopoulos; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

6.  Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.

Authors:  Mathilde Neuville; Najoua El-Helali; Eric Magalhaes; Aguila Radjou; Roland Smonig; Jean-François Soubirou; Guillaume Voiriot; Alban Le Monnier; Stéphane Ruckly; Lila Bouadma; Romain Sonneville; Jean-François Timsit; Bruno Mourvillier
Journal:  Ann Intensive Care       Date:  2017-03-22       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.